Evidence map›Paper›PMID 22246324›Full record

ArticleNature2012

Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion.

Teresa L M Thurston, Michal P Wandel, Natalia von Muhlinen, Agnes Foeglein, Felix Randow

Abstract read
In one paragraph

Article in Nature, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 612 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
612citing papers in PubMed, 1 pooled it
25.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

612 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,000 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. RNF213-dependent lytic destruction ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Selective autophagy in kidney health and disease.Nature reviews. Nephrology · 2026
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

552 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Teresa L M ThurstonMRC Laboratory of Molecular Biology, Division of Protein and Nucleic Acid Chemistry, Hills Road, Cambridge CB2 0QH, UK.
Michal P Wandel
Natalia von Muhlinen
Agnes Foeglein
Felix Randow
MRC Laboratory of Molecular Biology · GB

Funding

Medical Research Council MC_U105170648Medical Research Council U.1051.03.011(78825)
6 · The paper itself

Abstract

Autophagy defends the mammalian cytosol against bacterial infection. Efficient pathogen engulfment is mediated by cargo-selecting autophagy adaptors that rely on unidentified pattern-recognition or danger receptors to label invading pathogens as autophagy cargo, typically by polyubiquitin coating. Here we show in human cells that galectin 8 (also known as LGALS8), a cytosolic lectin, is a danger receptor that restricts Salmonella proliferation. Galectin 8 monitors endosomal and lysosomal integrity and detects bacterial invasion by binding host glycans exposed on damaged Salmonella-containing vacuoles. By recruiting NDP52 (also known as CALCOCO2), galectin 8 activates antibacterial autophagy. Galectin-8-dependent recruitment of NDP52 to Salmonella-containing vesicles is transient and followed by ubiquitin-dependent NDP52 recruitment. Because galectin 8 also detects sterile damage to endosomes or lysosomes, as well as invasion by Listeria or Shigella, we suggest that galectin 8 serves as a versatile receptor for vesicle-damaging pathogens. Our results illustrate how cells deploy the danger receptor galectin 8 to combat infection by monitoring endosomal and lysosomal integrity on the basis of the specific lack of complex carbohydrates in the cytosol.

Indexed as

AutophagyCell ProliferationCytoplasmCytoplasmic VesiclesEndosomesGalectinsHeLa CellsHumansLysosomesNuclear ProteinsSalmonella InfectionsSalmonella typhimuriumCALCOCO2 protein, humanGalectinsLGALS8 protein, humanNuclear Proteins

Identifiers

PMID22246324
PMCPMC3343631
OpenAlexW2140915719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.